Processing

Please wait...

Settings

Settings

1. WO2020006128 - CHEWABLE GEL COMPRISING LORATADINE

Publication Number WO/2020/006128
Publication Date 02.01.2020
International Application No. PCT/US2019/039322
International Filing Date 26.06.2019
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
68
chewing gum type
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
445
Non-condensed piperidines, e.g. piperocaine
4523
containing further heterocyclic ring systems
4545
containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37
Drugs for immunological or allergic disorders
08
Antiallergic agents
A61K 9/68 (2006.01)
A61K 31/4545 (2006.01)
A61P 37/08 (2006.01)
CPC
A61K 31/4545
A61K 47/12
A61K 47/26
A61K 47/36
A61K 9/0056
A61K 9/06
Applicants
  • SANTA CRUZ PHARMACEUTICALS, INC. [US/US]; 2200 Delaware Avenue Santa Cruz, California 95060, US
Inventors
  • SIMPSON, Michael A.; US
  • MINVILLE, Benoit; CA
  • BOST, William; US
Agents
  • SKLAR, Steven H.; US
  • SPINA, Kenneth P.; US
Priority Data
16/372,17701.04.2019US
62/690,32026.06.2018US
62/770,65921.11.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) CHEWABLE GEL COMPRISING LORATADINE
(FR) GEL À MÂCHER COMPRENANT DE LA LORATADINE
Abstract
(EN)
The invention provides a chewable gel dosage form that contains at least one active agent and a method of administering such chewable gel dosage form to subjects to treat one or more indications associated with the active agent(s). In one embodiment, the invention provides a method for the temporary relief of symptoms to due hay fever and upper respiratory allergies comprising administering to a subject in need thereof a chewable gel dosage form comprising a therapeutically effective amount of loratadine and a gelling agent, wherein therapeutic efficacy is achieved under fasted or fed conditions.
(FR)
L'invention concerne une forme pharmaceutique de gel à mâcher qui contient au moins un agent actif et un procédé d'administration d'une telle forme pharmaceutique de gel à mâcher à des sujets pour traiter une ou plusieurs indications associées à l'agent actif ou aux agents actifs. Dans un mode de réalisation, l'invention concerne un procédé pour le soulagement temporaire des symptômes du rhume des foins et des allergies des voies respiratoires supérieures comprenant l'administration à un sujet qui en a besoin d'une forme posologique de gel à mâcher comprenant une quantité thérapeutiquement efficace de loratadine et d'un agent gélifiant, l'efficacité thérapeutique étant obtenue à jeun ou après avoir mangé.
Latest bibliographic data on file with the International Bureau